What do systematic reviews say?

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 236 participants
  Low

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

The review found no eligible studies for this question.

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Social activities vs usual care

• Non‐pharmacological interventions for sleep disturbances in people with dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 236 participants
  Low

Summary of findings table ‐ Ibuprofen 1600 mg vs paracetamol

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 108 participants
  Moderate

Pregabalin 300 mg vs placebo

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 107 participants
  Low

Pregabalin 300 mg vs placebo

Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (nausea) compared with placebo (low certainty).

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  OR 0.85 [0.33, 2.19]
  1 study · 107 participants
  Low

Pregabalin 300 mg vs placebo

Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (vomiting) compared with placebo (low certainty).

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  OR 0.76 [0.35, 1.63]
  1 study · 107 participants
  Low

Pregabalin 300 mg vs placebo

Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in gastrointestinal side effects (diarrhoea) compared with placebo (low certainty).

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  OR 0.82 [0.38, 1.76]
  1 study · 107 participants
  Low

Pregabalin 300 mg vs placebo

The review found no eligible studies for this question.

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pregabalin 300 mg vs placebo

The review found no eligible studies for this question.

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pregabalin 300 mg vs placebo

The review found no eligible studies for this question.

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pregabalin 300 mg vs placebo

Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in patient satisfaction with analgesia compared with placebo (low certainty).

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  OR 0.97 [0.42, 2.21]
  1 study · 104 participants
  Low

Pregabalin 300 mg vs placebo

Summary of findings table ‐ Pregabalin 300 mg showed no clear difference in patient satisfaction with abortion care overall compared with placebo (low certainty).

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  OR 1.84 [0.8, 4.22]
  1 study · 105 participants
  Low

Summary of findings table ‐ Ibuprofen 1600 mg vs paracetamol

The review found no eligible studies for this question.

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Ibuprofen 1600 mg vs paracetamol

The review found no eligible studies for this question.

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Ibuprofen 1600 mg vs paracetamol

The review found no eligible studies for this question.

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Ibuprofen 1600 mg vs paracetamol

Summary of findings table ‐ Ibuprofen 1600 mg showed no clear difference in complete abortion rate compared with paracetamol 2000 mg (low certainty).

• Pain management for medical abortion before 14 weeks’ gestation 2022 · Cochrane Headline outcomes only
  OR 2.11 [0.64, 6.92]
  1 study · 108 participants
  Low